The Company is a pharmacogenomics company offering a full range of solutions to support key steps of the drug discovery and development process, extending from drug target identification through clinical trials to commercialization. The Company intends to establish multiple sources of revenue that will include collaboration revenues, license fees, milestone payments and royalties on products commercialized using its technology.
Revenues reflect higher collaboration revenues.
Lower loss also reflects the absence of preferred dividend payments. Market Guide offers more in-depth Company Research , Stock Screening , and Hottest Stocks and Industries on over 10,000 U.S. Equities. All Rights Reserved. Privacy Policy - Terms of Service Company information Copyright Market Guide . Some event data provided by StreetEvents .